Texture analysis of advanced non-small cell lung cancer (NSCLC) on contrast-enhanced computed tomography: prediction of the response to the first-line chemotherapy
暂无分享,去创建一个
Roberto Maroldi | Marco Ravanelli | Mauro Morassi | M. Ravanelli | D. Farina | R. Maroldi | M. Morassi | E. Roca | G. Cavalleri | G. Tassi | Davide Farina | Elisa Roca | Giuseppe Cavalleri | Gianfranco Tassi
[1] Jia-Yu Sun,et al. Peripheral lung carcinoma: correlation of angiogenesis and first-pass perfusion parameters of 64-detector row CT. , 2008, Lung cancer.
[2] Xianrang Song,et al. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1α gene , 2006, Cancer Chemotherapy and Pharmacology.
[3] Vicky Goh,et al. Assessment of tumor heterogeneity by CT texture analysis: can the largest cross-sectional area be used as an alternative to whole tumor analysis? , 2013, European journal of radiology.
[4] A. Padhani. MRI for assessing antivascular cancer treatments. , 2003, The British journal of radiology.
[5] Vicky Goh,et al. Operable non-small cell lung cancer: correlation of volumetric helical dynamic contrast-enhanced CT parameters with immunohistochemical markers of tumor hypoxia. , 2012, Radiology.
[6] C. Yi,et al. Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density. , 2004, Radiology.
[7] R. Souhami,et al. Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life , 2004, Thorax.
[8] A. Alavi,et al. Non-FDG PET in the practice of oncology. , 2010, Indian journal of cancer.
[9] M. Okada,et al. [New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)]. , 2009, Gan to kagaku ryoho. Cancer & chemotherapy.
[10] T. Shanafelt,et al. Are chemotherapy response rates related to treatment-induced survival prolongations in patients with advanced cancer? , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] K. Miles,et al. Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival , 2012, European Radiology.
[12] Masahiko Kusumoto,et al. Contrast‐enhanced dynamic computed tomography for the evaluation of tumor angiogenesis in patients with lung carcinoma , 2002, Cancer.
[13] V. Goh,et al. Non-small cell lung cancer: histopathologic correlates for texture parameters at CT. , 2013, Radiology.
[14] K. Miles,et al. Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. , 2012, Clinical radiology.
[15] G. Bepler,et al. Parameters for individualizing systemic therapy in non-small cell lung cancer. , 2010, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[16] Balaji Ganeshan,et al. Colorectal cancer: texture analysis of portal phase hepatic CT images as a potential marker of survival. , 2009, Radiology.